Showing results (181-190 of 634) with videos related to

Sort By:
Pageof 64
Endocrine Pathology|May 4, 2020
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)Marco Schiavo Lena, Stefano Partelli, Paola Castelli, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|July 17, 2020
Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasmsSara Loi, Martina Mori, Giulia Benedetti, et al.
Annals of Surgery|June 16, 2023
Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After PancreatoduodenectomyGiampaolo Perri, Giovanni Marchegiani, Stefano Partelli, et al.
Annals of Surgery|May 15, 2012
Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1Caroline L Lopez, Massimo Falconi, Jens Waldmann, et al.
Surgery|March 17, 2023
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancerAlessandro Cucchetti, Benjamin Djulbegovic, Stefano Crippa, et al.
European Journal of Internal Medicine|January 6, 2020
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related diseaseCorrado Campochiaro, Emanuel Della-Torre, Marco Lanzillotta, et al.
La Radiologia Medica|June 8, 2023
Limited impact of discretization/interpolation parameters on the predictive power of CT radiomic features in a surgical cohort of pancreatic cancer patientsSara Loi, Martina Mori, Diego Palumbo, et al.
Annals of Surgical Oncology|February 22, 2026
Risk Factors for Early Disease-Related Mortality Among Patients with Localized Pancreatic Cancer Resected After Neoadjuvant TreatmentFederico De Stefano, Giulio Belfiori, Giuseppe Malleo, et al.
Arthritis Research & Therapy|October 5, 2018
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapseMarco Lanzillotta, Emanuel Della-Torre, Raffaella Milani, et al.
Clinical and Experimental Rheumatology|January 18, 2019
Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related diseaseMarco Lanzillotta, Emanuel Della-Torre, Raffaella Milani, et al.
Pageof 64